29 April 2024


Search Results for Tag : Nevirapine

News

Indian Patent Office Disallows Patent for Boehringer Ingelheim’s HIV Drug, Nevirapine(21.10.2015)

Indian Patent Office has disallowed Germany's Boehringer Ingelheim a patent on its HIV drug, Nevirapine, sold as Viramune XR (extended release), yet a.....

Tags : Boehringer Ingelheim, Patent , HIV Drug, Nevirapine

read»